Clinical Trials Logo

Clinical Trial Summary

This is a pilot study to test the short-term effectiveness of an alternative treatment approach for precancerous cells of the cervix. The study will also explore whether this new treatment is feasible to perform and if it is acceptable to patients.


Clinical Trial Description

Standard treatment for precancerous cells of the cervix is called electrosurgical excision procedure (LEEP). Standard LEEP involves treating the entire cervix using FDA-approved equipment. Focal LEEP utilizes the same surgery and the same equipment but only treats the visually unhealthy part of the cervix and not the entire cervix. Side effects and unusual symptoms will be monitored as well as the patient's thoughts and recommendations of the procedure. The total amount of time of study participation is six months. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02220192
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Completed
Phase N/A
Start date December 2014
Completion date March 2016

See also
  Status Clinical Trial Phase
Completed NCT01709773 - Focal Ablation of Cervical Precancer N/A
Completed NCT03239223 - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection Phase 1
Active, not recruiting NCT01511328 - Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm N/A
Completed NCT03697226 - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. Phase 1